361 related articles for article (PubMed ID: 16278378)
1. Signal pathway of hypoxia-inducible factor-1alpha phosphorylation and its interaction with von Hippel-Lindau tumor suppressor protein during ischemia in MiaPaCa-2 pancreatic cancer cells.
Kwon SJ; Song JJ; Lee YJ
Clin Cancer Res; 2005 Nov; 11(21):7607-13. PubMed ID: 16278378
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway.
Yoo YG; Oh SH; Park ES; Cho H; Lee N; Park H; Kim DK; Yu DY; Seong JK; Lee MO
J Biol Chem; 2003 Oct; 278(40):39076-84. PubMed ID: 12855680
[TBL] [Abstract][Full Text] [Related]
3. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
4. Hypoxic induction of HIF-1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases.
Shemirani B; Crowe DL
Oral Oncol; 2002 Apr; 38(3):251-7. PubMed ID: 11978547
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma.
Turcotte S; Desrosiers RR; Beliveau R
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F338-48. PubMed ID: 14583436
[TBL] [Abstract][Full Text] [Related]
6. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation.
Zhou J; Schmid T; Frank R; Brüne B
J Biol Chem; 2004 Apr; 279(14):13506-13. PubMed ID: 14726529
[TBL] [Abstract][Full Text] [Related]
7. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
8. JNK1 mediates degradation HIF-1alpha by a VHL-independent mechanism that involves the chaperones Hsp90/Hsp70.
Zhang D; Li J; Costa M; Gao J; Huang C
Cancer Res; 2010 Jan; 70(2):813-23. PubMed ID: 20068160
[TBL] [Abstract][Full Text] [Related]
9. Microtubular stability affects pVHL-mediated regulation of HIF-1alpha via the p38/MAPK pathway in hypoxic cardiomyocytes.
Teng M; Jiang XP; Zhang Q; Zhang JP; Zhang DX; Liang GP; Huang YS
PLoS One; 2012; 7(4):e35017. PubMed ID: 22506063
[TBL] [Abstract][Full Text] [Related]
10. The interaction between Toll-like receptor 4 signaling pathway and hypoxia-inducible factor 1α in lung ischemia-reperfusion injury.
Zhou Z; Zhu X; Chen J; Yang S; Sun R; Yang G
J Surg Res; 2014 May; 188(1):290-7. PubMed ID: 24472280
[TBL] [Abstract][Full Text] [Related]
11. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
[TBL] [Abstract][Full Text] [Related]
12. Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel-Lindau-dependent pathway.
Li CH; Liao PL; Yang YT; Huang SH; Lin CH; Cheng YW; Kang JJ
Arch Toxicol; 2014 Mar; 88(3):659-71. PubMed ID: 24292262
[TBL] [Abstract][Full Text] [Related]
13. Melatonin and the von Hippel-Lindau/HIF-1 oxygen sensing mechanism: A review.
Vriend J; Reiter RJ
Biochim Biophys Acta; 2016 Apr; 1865(2):176-83. PubMed ID: 26899267
[TBL] [Abstract][Full Text] [Related]
14. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
15. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species produced by the knockdown of manganese-superoxide dismutase up-regulate hypoxia-inducible factor-1alpha expression in oral squamous cell carcinoma cells.
Sasabe E; Yang Z; Ohno S; Yamamoto T
Free Radic Biol Med; 2010 May; 48(10):1321-9. PubMed ID: 20188165
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of salutary effects of melatonin-mediated liver protection after trauma-hemorrhage: p38 MAPK-dependent iNOS/HIF-1α pathway.
Hsu JT; Le PH; Lin CJ; Chen TH; Kuo CJ; Chiang KC; Yeh TS
Am J Physiol Gastrointest Liver Physiol; 2017 May; 312(5):G427-G433. PubMed ID: 28254774
[TBL] [Abstract][Full Text] [Related]
19. HIF-1alpha activation by a redox-sensitive pathway mediates cyanide-induced BNIP3 upregulation and mitochondrial-dependent cell death.
Zhang L; Li L; Liu H; Prabhakaran K; Zhang X; Borowitz JL; Isom GE
Free Radic Biol Med; 2007 Jul; 43(1):117-27. PubMed ID: 17561100
[TBL] [Abstract][Full Text] [Related]
20. Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling.
Doronzo G; Russo I; Mattiello L; Riganti C; Anfossi G; Trovati M
Diabetologia; 2006 May; 49(5):1049-63. PubMed ID: 16506055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]